Hepatitis c virus infection Trials in Philadelphia, United States
Conditions / Hepatitis c virus infection / Philadelphia, United States
Clinical trials for Hepatitis c virus infection investigate a range of treatment strategies and patient populations.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02639247 | Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor | COMPLETED | PHASE3 |
| NCT02346721 | Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection | COMPLETED | PHASE3 |
| NCT02220998 | Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection | COMPLETED | PHASE3 |
| NCT02201953 | Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection | COMPLETED | PHASE3 |
| NCT01428063 | Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials | COMPLETED | PHASE2 |
| NCT05363865 | Digital Community to Improve Health in Rural Areas | COMPLETED | NA |
| NCT02510300 | A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials | TERMINATED | — |
| NCT02201901 | Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis | COMPLETED | PHASE3 |
| NCT02201940 | Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection | COMPLETED | PHASE3 |
| NCT02292706 | A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection | TERMINATED | — |